Aims and scope

Archives of Disease in Childhood is an international peer review journal that aims to keep paediatricians and others up to date with advances in the diagnosis and treatment of childhood diseases as well as advocacy issues such as child protection. It focuses on all aspects of child health and disease from the perinatal period (in the Fetal and Neonatal edition) through to adolescence. ADC includes original research reports, commentaries, reviews of clinical and policy issues, and evidence reports. Areas covered include: community child health, public health, epidemiology, acute paediatrics, advocacy, and ethics.

The content of Archives of Disease in Childhood is endorsed by the Royal College of Paediatrics and Child Health for Continued Professional Development in line with RCPCH CPD guidelines.

Editorial Board

For information about the Editor-in-Chief and editorial team, please refer to the Editorial Board page.


ADC is co-owned by the Royal College of Paediatrics and Child Health and BMJ. For more information please refer to the Affiliations section below.


Education and Practice edition

This edition of ADC published six times per year (launched in 2004) aims to assist paediatricians, at all levels in their training, in their ongoing professional development. The edition is supported by the RCPCH but has international appeal. The journal contains the following educational sections :

  • Best practice
  • Problem solving in clinical practice
  • Pharmacy update
  • Evidence-based paediatrics (Picket)
  • Interpretations (making sense of diagnostic tests)
  • Radiology (Illuminations) and dermatology (Dermatophile) quizzes

For more information please read the editorial that appeared in the first issue.

The Fetal and Neonatal edition

This bimonthly edition of ADC brings together quality research and reviews in the field of perinatal and neonatal medicine. Original research papers cover fetal and neonatal physiology and clinical practice, genetics, perinatal epidemiology and neurodevelopmental outcomes.

Paediatric and Perinatal Drug Therapy

Four times a year ADC will carry a distinct Paediatric and Perinatal Drug Therapy (PPDT) section publishing original research, reviews, comment and analysis in all areas of paediatric drug therapy. The current editors of PPDT, Imti Choonara, Tony Nunn and Michael Rieder will be the editors of this section.

As well as being published in print and online in ADC the section will be reprinted and sent to all members of the European Society for Developmental Perinatal and Paediatric Pharmacology and the Neonatal and Paediatric Pharmacists Group. All subscribers to ADC will have access to PPDT papers.

Journal Information

Publication Model Subscription; with hybrid open access option
Frequency ADC is published monthly E&P and FNN are published bimonthly
Launch date 1926
Indexed by Index Medicus (Medline), ISI Current Contents (Web of Science), Excerpta Medica (Embase)
Impact Factor ADC: 3.265 EP: 1.215 FNN: 3.786
Peer Review Model Single blind; the names of reviewers are hidden from the author
ADC Print ISSN 0003-9888
FNN Online ISSN 1468-2052
FNN Print ISSN 1359-2998
E&P Online ISSN 1743-0593
E&P Print ISSN 1743-0585

Journal Statistics

Acceptance Rate 19% for original research submitted in 2016
Time from submission to first decision 28 days
Time from acceptance to publication 17 days (online) 4 months (print)

Contact Information

For all contact information please refer to the Contact Us page.

For Authors

Please refer to the Instructions for Authors


To advertise

Rights and Permissions


Members receive print/online access to ADC

COPE logo

The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

Equator logo

The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.